Literature DB >> 2542154

Galactose-1-phosphate uridyl transferase in density-fractionated erythrocytes. Studies of normal and mutant enzymes.

R I Kelley1, D M Feinberg, S Segal.   

Abstract

Galactose-1-phosphate uridyl transferase (GALT), the deficient enzyme in classical galactosemia, was studied by Percoll-gradient age-fractionation of erythrocytes. For normal GALT, a rapid and substantial decrease in GALT activity and loss of most of two isozymes was found to occur in the reticulocyte fractions. The loss of activity was then followed by relative stabilization of both GALT-specific activity and microheterogeneity in mature and aging erythrocytes. When applied to the study of mutant GALT from galactosemic patients, the Percoll-gradient fractionation method permitted detection in the reticulocyte-enriched fractions of up to 5% of normal GALT-specific activity and an isoelectric focusing pattern essentially the same as that of normal GALT. Percoll-gradient fractionation of erythrocytes offers a simple and direct method to study characteristics of GALT activity and microheterogeneity in normal and galactosemic human erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542154     DOI: 10.1007/bf00284037

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  19 in total

1.  The age related loss of activity of four enzymes in the human erythrocyte.

Authors:  B M Turner; R A Fisher; H Harris
Journal:  Clin Chim Acta       Date:  1974-01-19       Impact factor: 3.786

2.  An association between the kinetic and electrophoretic properties of human purine-nucleoside-phosphorylase isozymes.

Authors:  B M Turner; R A Fisher; H Harris
Journal:  Eur J Biochem       Date:  1971-12

3.  Characteristics of galactose-1-phosphate uridyl transferase in intestinal mucosa of normal and galactosemic humans.

Authors:  S Rogers; P G Holtzapple; W J Mellman; S Segal
Journal:  Metabolism       Date:  1970-09       Impact factor: 8.694

4.  The genetic defect in galactosemia.

Authors:  T A Tedesco; J W Wu; F S Boches; W J Mellman
Journal:  N Engl J Med       Date:  1975-04-03       Impact factor: 91.245

5.  How do red cell enzymes age? A new perspective.

Authors:  E Beutler
Journal:  Br J Haematol       Date:  1985-11       Impact factor: 6.998

6.  Liver galactose-1-phosphate uridyl transferase: activity in normal and galactosemic subjects.

Authors:  S Segal; S Rogers; P G Holtzapple
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

7.  Homocystinuria: biogenesis of cystathionine beta-synthase subunits in cultured fibroblasts and in an in vitro translation system programmed with fibroblast messenger RNA.

Authors:  F Skovby; J P Kraus; L E Rosenberg
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

8.  Galactosemia: evidence for a structural gene mutation.

Authors:  T A Tedesco; W J Mellman
Journal:  Science       Date:  1971-05-14       Impact factor: 47.728

9.  Transferase-deficiency galactosemia: evidence for the lack of a transferase protein in galactosemic red cells.

Authors:  M W Andersen; V P Williams; G R Helmer; C Fried; G Popják
Journal:  Arch Biochem Biophys       Date:  1983-04-01       Impact factor: 4.013

10.  Galactosemia: how does long-term treatment change the outcome?

Authors:  R Gitzelmann; B Steinmann
Journal:  Enzyme       Date:  1984
View more
  3 in total

Review 1.  Regulation of galactose metabolism: implications for therapy.

Authors:  S Segal; S Rogers
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Molecular analysis of 11 galactosemia patients.

Authors:  J K Reichardt
Journal:  Nucleic Acids Res       Date:  1991-12       Impact factor: 16.971

3.  Molecular characterization of two galactosemia mutations: correlation of mutations with highly conserved domains in galactose-1-phosphate uridyl transferase.

Authors:  J K Reichardt; S Packman; S L Woo
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.